FIELD: medicine, phthisiology. SUBSTANCE: invention relates to an agent for treatment of tuberculosis with low level of fibrotic complications that presents a conjugate of isoniazide-dextran of molecular mass 65-75 kDa of the formula: where R1 is H, glucose residue or polyglucosyl residue of the formula given in picture above; R2 is isoniazide residue of the formula: or hydroxyl-group. Agent shows the significantly less level of fibrotic complications as compared with isoniazide-dextran of molecular mass 40 kDa in using in equal doses by isoniazide and similar schedule treatment. EFFECT: improved curative properties, decreased complications in treatment. 2 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT WITH LOW HEPATOTOXICITY FOR TREATMENT OF TUBERCULOSIS PATIENTS | 1999 |
|
RU2168994C1 |
ISONIAZID-DEXTRAN CONJUGATE AND APPLICATION THEREOF | 1999 |
|
RU2163120C1 |
METHOD OF TREATMENT THE GENERAL TUBERCULOSIS PROCESS IN EXPERIMENT | 1993 |
|
RU2087146C1 |
PHARMACEUTICAL TUBERCULOSIS COMPOSITION | 2008 |
|
RU2372914C1 |
METHOD FOR PRODUCING PROLONGED ACTION ISONIASIDE | 2000 |
|
RU2192865C2 |
METHOD FOR in vitro RECOVERY OF EXPERIMENTAL TUBERCULOUS GRANULOMA IN CULTURES | 2010 |
|
RU2447419C2 |
METHOD OF PREPARING ANTIGEN FROM MYCOBACTERIUM TUBERCULOSIS CELLS FOR DIAGNOSTICUM CONSTRUCTION | 1994 |
|
RU2095816C1 |
ANTITUBECULOUS-CAUSED MEDICAMENTOUS POLYNEUROPATHY APPROACH | 2007 |
|
RU2353360C2 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS AT PREDOMINANTLY PRODUCTIVE TYPE OF TISSUE REACTION | 2000 |
|
RU2204409C2 |
METHOD OF PREPARING A CONJUGATE ISONIAZID-DEXTRAN | 1994 |
|
RU2125451C1 |
Authors
Dates
2002-07-20—Published
2000-04-03—Filed